Processing

Please wait...

Settings

Settings

1. WO2020002905 - CANCER THERAPY


Disclaimer The image version (PDF) available on PATENTSCOPE is the official version. This online html version is provided to assist users. Despite the great care taken in its compilation to ensure a precise and accurate representation of the data appearing on the printed document/images, errors and/or omissions cannot be excluded due to the data transmittal, conversion and inherent limitations of the (optional) machine translation processes used. Hyperlinks followed by this symbol , are to external resources that are not controlled by WIPO. WIPO disclaims all liability regarding the above points.

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/GB2019/051794 JWJ02444WO
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
25 June 2019 25 June 2018
Applicant
IMMODULON THERAPEUTICS LIMITED
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No.     1    
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     A61K 39/395 (2006.01)i; A61K 35/74 (2015.01)i; C07K 16/28 (2006.01)i; A61P 35/04 (2006.01)i; A61P 35/00 (2006.01)i; A61K 45/06 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     A61K; C07K; A61P
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal, BIOSIS, EMBASE, WPI Data

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
X
WO 2016207646 A1 (IMMODULON THERAPEUTICS LIMITED [GB]) 29 December 2016 (2016-12-29)
1-15,17,28-56
Y
page 11, paragraph 4; claims 1-39; figures 1-3
16,27,57
page 4, paragraph 4
page 12, paragraph 6
(2)
X
WO 2015092382 A1 (IMMODULON THERAPEUTICS LTD [GB]) 25 June 2015 (2015-06-25)
1-15,17-26,28-56
page 4, paragraph 4; claims 1-34; figure 1
(3)
Y
WO 2016015095 A1 (UNIV WESTERN AUSTRALIA [AU]; TELETHON KIDS INST [AU]) 04 February 2016 (2016-02-04)
16,27,57
[0051];claims 12, 15
(4)
Y
WO 2017004079 A1 (BIOMED VALLEY DISCOVERIES INC [US]) 05 January 2017 (2017-01-05)
16
[0045]
(5)
A,P
ANGUS G. DALGLEISH ET AL, "Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity", JOURNAL OF TRANSLATIONAL MEDICINE,Vol. 16, No. 1, 14 August 2018 (2018-08-14),
XP055572142
1-57
page 4 - page 6
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"D"
document cited by the applicant in the international application
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family

D. INFORMATION ON PATENT FAMILY MEMBERS

Patent document cited in search report Publication date
(day/month/year)
Patent family member(s) Publication date
(day/month/year)
WO 2016207646 A1
29 December 2016
AU 2016281765 A1
BR 112017028163 A2
CA 2990107 A1
CN 107847598 A
EP 3319635 A1
JP 2018518539 A
KR 20180015269 A
RU 2018102547 A
US 2018185479 A1
WO 2016207646 A1
18 January 2018
28 August 2018
29 December 2016
27 March 2018
16 May 2018
12 July 2018
12 February 2018
24 July 2019
05 July 2018
29 December 2016
WO 2015092382 A1
25 June 2015
AU 2014369510 A1
CA 2932659 A1
CN 105979964 A
EP 3082956 A1
JP 2017500341 A
KR 20160093023 A
RU 2016123370 A
SG 11201604602T A
US 2017028047 A1
US 2019008942 A1
WO 2015092382 A1
30 June 2016
25 June 2015
28 September 2016
26 October 2016
05 January 2017
05 August 2016
25 January 2018
28 July 2016
02 February 2017
10 January 2019
25 June 2015
WO 2016015095 A1
04 February 2016
EP 3195168 A1
US 2017218068 A1
WO 2016015095 A1
26 July 2017
03 August 2017
04 February 2016
WO 2017004079 A1
05 January 2017
EP 3313186 A1
JP 2018519324 A
US 2017007587 A1
US 2018117020 A1
WO 2017004079 A1
02 May 2018
19 July 2018
12 January 2017
03 May 2018
05 January 2017
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
10 September 2019
Date of mailing of the international search report:
25 September 2019
Authorized officer:
Klee, Barbara
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E